Chemung Financial Reports Q4 Tangible Book Value of $48.43
Reports Q4 tangible book value per share $48.43. "Fourth quarter results highlight the sustained benefits of the Corporation's strategic repositioning efforts throughout the year," said Anders Tomson, president and CEO of Chemung Financial. "Meaningful expansion in net interest margin of 16 basis points compared to the prior quarter, combined with strong commercial loan growth across key markets, reflects our continued ability to support high-quality client demand while maintaining disciplined funding cost management," Tomson added.
Trade with 70% Backtested Accuracy
Analyst Views on CHMG
About CHMG
About the author

- Earnings Performance: Chemung Financial's Q4 GAAP EPS of $1.61 aligns with market expectations, demonstrating the company's ongoing commitment to maintaining stable profitability.
- Significant Revenue Growth: The company reported revenue of $30.51 million, a 17.9% year-over-year increase, exceeding market expectations by $1.03 million, indicating strong business momentum, particularly in lending and deposit services.
- Positive Market Reaction: The revenue beat may positively impact Chemung Financial's stock price, enhancing investor confidence in its future growth potential.
- Strong Financial Health: The continuous revenue growth and stable profitability suggest a solid financial position, providing a robust foundation for future investments and expansion.
- Earnings Estimate Cut: Chemung Financial Corporation's current year earnings estimate has been revised downward by 3.9% over the last 60 days, indicating potential profitability challenges that could negatively impact its stock performance.
- Industry Impact: Similarly, Archer-Daniels-Midland Company's earnings estimate has been cut by 4%, reflecting overall weakness in the agricultural commodities sector, which may lead to decreased investor confidence.
- Market Reaction: Cool Company Ltd. has seen a 6% downward revision in its earnings estimate, raising concerns about the liquefied natural gas transportation industry and potentially affecting its future financing capabilities.
- Investment Recommendations: Zacks Investment Research has highlighted five top stock picks, and despite inherent risks, stocks like Hims & Hers Health have previously surged by 209%, showcasing the diverse potential within the market.
Earnings Growth: CHEMUNG FINANCIAL CORP reported third-quarter earnings of $7.79 million, or $1.62 per share, an increase from $5.72 million, or $1.19 per share, in the previous year.
Interest and Dividend Income: The company's total interest and dividend income rose to $33.88 million compared to $32.36 million last year.
Dividend Increase Announcement: Chemung Financial Corporation has approved a $0.02 increase in its quarterly dividend, raising it to $0.34 per share, payable on October 1, 2025.
Percentage Increase: This increase represents a 6.3% rise over the previous dividend and brings the total cumulative increase for 2025 to $0.03 per share, or 9.7%.
Company Background: Chemung Financial Corporation is a $2.9 billion financial services holding company based in Elmira, New York, operating through its subsidiary, Chemung Canal Trust Company, which is the oldest community bank in New York State.
Additional Services: The corporation also includes CFS Group, Inc., offering various non-traditional financial services such as mutual funds, annuities, brokerage, tax preparation, and insurance.
Earnings Performance: Chemung Financial Corp reported a loss of $6.45 million in Q2, compared to a profit of $4.99 million in the same period last year, with an EPS of -$1.35 versus $1.05 previously.
Analyst Expectations: Analysts had projected an earnings per share (EPS) of $0.39 for the quarter.
Positive Earnings Outlook for Chemung Financial: Analysts are increasingly optimistic about Chemung Financial's earnings, leading to higher estimates and a Zacks Rank #1 (Strong Buy), suggesting potential stock price growth.
Recent Stock Performance: The stock has gained 6.3% over the past month due to strong estimate revisions, making it an attractive option for investors looking to enhance their portfolios.










